<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Pharmacies on 0x000216</title><link>https://Nexus-Security.github.io/tags/pharmacies/</link><description>Recent content in Pharmacies on 0x000216</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Mon, 24 Jul 2023 08:18:30 +0000</lastBuildDate><atom:link href="https://Nexus-Security.github.io/tags/pharmacies/index.xml" rel="self" type="application/rss+xml"/><item><title>Demonstrating the Efficacy of Health Interventions in Cases of Free Movement</title><link>https://Nexus-Security.github.io/demonstrating-the-efficacy-of-health-interventions-in-cases-of-free-movement/</link><pubDate>Mon, 24 Jul 2023 08:18:30 +0000</pubDate><guid>https://Nexus-Security.github.io/demonstrating-the-efficacy-of-health-interventions-in-cases-of-free-movement/</guid><description>Angus MacCulloch, Lancaster University Law School
Two recent rulings concerning the free movement of goods (Articles 34/36 TFEU) highlight the critical importance of strong evidence when governments attempt to justify public health interventions in the market. The first example, a judgment from the Court of Justice of the European Union (CJEU) in Case C-148/15 Deutsche Parkinson Vereinigung, addressed the legality of fixed prices for prescription medicines in Germany. The second, a ruling from the Inner House of the Court of Session in Scotland in Scotch Whisky Assoc v LA [2016] CSIH 77, upheld the Scottish Government&amp;rsquo;s plan to introduce minimum unit pricing (MUP) for alcohol, finding it compatible with Article 34.</description></item></channel></rss>